To establish a new system for accurate classification and efficacy evaluation of primary aldosteronism (PA)

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300070845

Enrollment

Unknown

Registered

2023-04-24

Start date

2022-07-08

Completion date

Unknown

Last updated

2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary aldosteronism

Interventions

Surgical treatment group:N/A

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Age between 20 and 70 years old; 2.Confirmed diagnosis of primary aldosteronism by saline infusion test; 3.Dominant secretion in bilateral adrenal vein sampling and planned for surgical treatment.

Exclusion criteria

Exclusion criteria: 1.Renal insufficiency (GFR 2.5 times the upper limit of normal); 3.Patients with heart failure (NYHA functional class 3 and above, or EF 1.8ug/L.

Design outcomes

Secondary

Measure	Time frame
Laboratory indicators (liver and kidney function, electrolytes, blood lipids, blood glucose);Hormones (Cortisol, Catecholamine hormones, Aldosterone, Thyroid function, Sex hormones);Body composition(Inbody);	—

Primary

Measure	Time frame
Energy metabolism(HR,VO2,VCO2,EE,RQ);	—

Countries

China

Contacts

Public ContactWang Weiqing

Ruijin Hospital, Shanghai Jiaotong University, School of Medicine

wqingw@shsmu.edu.cn+86 18917762201

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026